Will Aurora (TSX:ACB) Stock Rise Like a Phoenix in 2020?

Aurora stock dropped like a rock in 2019, but has the opportunity to rebound in 2020.

| More on:
falling red arrow and lifting

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Make no mistake about it, Aurora Cannabis (TSX:ACB)(NYSE:ACB) had a horrific 2019.

Over those 12 months, Aurora lost nearly 63% of its share value, making it one of the worst-performing cannabis stocks of the year. Almost all cannabis stocks had a rough and rocky 2019, but things were especially awful for ACB.

The even worse news is that 2020 hasn’t exactly kicked off with a bang for Aurora, either. Individual shares closed on December 31, 2019, at $2.78 before dropping as low as $1.99 on January 13, 2020. The value of ACB has rebounded a little bit since then, with the stock closing at $2.68 on January 15.

The overall market sentiment regarding Aurora is lukewarm at best, but there’s a lot of opportunities here for those confident in Aurora rebounding over the next 12 months.

Here’s why Aurora has the potential to rebound in a big way through 2020 and beyond.

Regulatory roadblocks are disappearing

The Canadian cannabis industry started red-hot before cooling down considerably throughout 2019. 2020 looks like it could be another bull year for investors willing to ride out the storm with stocks like Aurora in their portfolio.

A lot of the gridlock that brought the cannabis industry in Canada to a screeching halt over the past 12 months is finally starting to dissipate. This is especially true in Ontario, the largest province in Canada by population, where local regulations and laws governing cannabis sales were previously very restrictive.

The overall process for gaining a legal retail license to sell cannabis in Canada has been streamlined significantly. This means more retail stores reaching more customers, and that means more business for Aurora.

Investment in derivative products

On top of that, Aurora is looking to shift some of its business focus away from traditional cannabis products to secondary solutions that the company will produce and sell to their wholesale/retail partners.

The company has heavily invested in these derivative products that are already proving to be very popular with cannabis customers in Canada, and expect to have significant shipments of these solutions ready to go to individual retailers throughout Canada during the first quarter of 2020.

Depending on how these new products roll out during the first quarter of 2020 will not likely have a considerable impact on Q1 financial reporting, though. This means that individual investors have an opportunity to strike while the Aurora share value remains low with plenty of growth and upside for the rest of the year when these numbers climb.

Foolish takeaway

Combine all of that with the major waves that Aurora is making in the U.S. cannabis market, and it’s easy to see why so many believe that this company has the potential to rebound in a big way.

Investors have every reason to be at least a little gun shy about the prospects of Aurora turning things around. But, with new leadership pushing this company in a new direction while doubling down on the matters the company already does well, the recipe for wild success certainly exists.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »